Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-200a-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 175, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
CCND2 hsa-miR-200a-5p low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:4304463-4304489 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:4300623-4300649 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:4300623-4300649 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:4300623-4300649 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:4300623-4300649 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:4300623-4300649 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUFIP2 hsa-miR-200a-5p low: 0 high: 5 1 1 1 0.614
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:29261378-29261405 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29261378-29261405 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29261378-29261405 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:29261378-29261405 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:29261378-29261405 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MLK4 hsa-miR-200a-5p low: 0 high: 4 1 1 1 0.627
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:233379012-233379038 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:233379012-233379038 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:233379012-233379038 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:233379012-233379038 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RC3H2 hsa-miR-200a-5p low: 0 high: 3 1 1 1 0.818
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr9:122848135-122848159 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr9:122848135-122848159 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:122848135-122848159 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RPS29 hsa-miR-200a-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr14:49586344-49586372 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr14:49586344-49586372 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr14:49586344-49586372 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TXNIP hsa-miR-200a-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:145992818-145992845 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:145992818-145992845 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:145992818-145992845 HITS-CLIP POSITIVE DIRECT TarBase 7.0
USP33 hsa-miR-200a-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:77728408-77728426 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:77728408-77728426 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:77728408-77728426 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCNJ hsa-miR-200a-5p low: 0 high: 3 1 1 1 0.630
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr10:96060214-96060241 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:96060214-96060241 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:96060214-96060241 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KIAA1033 hsa-miR-200a-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr12:105167148-105167171 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr12:105167582-105167608 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:105156737-105156758 HITS-CLIP POSITIVE DIRECT TarBase 7.0
OTUD3 hsa-miR-200a-5p low: 0 high: 3 1 1 1 0.606
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:19912859-19912886 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:19912859-19912886 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:19912859-19912886 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCNE2 hsa-miR-200a-5p low: 0 high: 3 1 1 1 0.566
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:94881406-94881430 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:94881406-94881430 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:94881406-94881430 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF526 hsa-miR-200a-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:42225109-42225136 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:42225109-42225136 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:42225109-42225136 HITS-CLIP POSITIVE DIRECT TarBase 7.0
VEZT hsa-miR-200a-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:95257201-95257222 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:95257201-95257222 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARNTL2 hsa-miR-200a-5p low: 0 high: 2 1 1 1 0.705
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:27421108-27421130 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:27421108-27421130 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CBX5 hsa-miR-200a-5p low: 0 high: 2 1 1 1 0.541
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:54241463-54241491 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:54233127-54233149 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF4G1 hsa-miR-200a-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr3:184323545-184323573 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr3:184324966-184324988 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NEK4 hsa-miR-200a-5p low: 0 high: 2 1 1 1 0.620
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr3:52710961-52710983 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr3:52710961-52710983 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MRPS7 hsa-miR-200a-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:75265861-75265881 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:75265861-75265881 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SCARB2 hsa-miR-200a-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:76161232-76161254 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr4:76161232-76161254 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GIGYF1 hsa-miR-200a-5p low: 0 high: 2 2 2 2 0.569
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr7:100681741-100681765 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr7:100680505-100680529 HITS-CLIP POSITIVE DIRECT TarBase 7.0